Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit–risk assessment by VTE risk in SAVE-ONCO - George, D; Agnelli, G; Fisher, W (Blood, 2011)
abstr206 2011.